Na Wang1, HuaGuang Yang1, ChengBo Li1, GuoGuang Fan2, XiaoGuang Luo3. 1. Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China. 2. Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China. fanguog@sina.com. 3. Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China. grace_shenyang@163.com.
Abstract
OBJECTIVE: To investigate the value of 'swallow-tail' sign and putaminal hypointensity on 3 T susceptibility-weighted imaging (SWI) for distinguishing multiple system atrophy (MSA) from idiopathic Parkinson's disease (IPD). METHODS: Three groups - 39 MSA patients, 18 IPD patients,and 31 healthy controls (HCs) - were administered a 3 T SWI sequence to evaluate 'swallow-tail' sign and putaminal hypointensity using visual scales from 0 to 2 and 0 to 3 scores, respectively. The diagnostic accuracy of the two signs separately and combined was calculated using a receiver operating characteristic curve, with clinical diagnosis as the gold standard. RESULTS: The scores of 'swallow-tail' sign were lower in IPD than in MSA or in HCs, as well as for putaminal hypointensity in IPD or HCs than in MSA (p < 0.05). The sensitivity and specificity of 'swallow-tail' sign and putaminal hypointensity were 87.9% and 83.3%, and 35.9% and 100%, respectively, in the respective patient groups. The area under the curve of combined signs was increased from 0.85 ('swallow tail') or 0.68 (putaminal hypointensity) to 0.93. CONCLUSION: The combination of 'swallow-tail' sign and putaminal hypointensity can increase the accuracy of discriminating between MSA and IPD. KEY POINTS: • Differential diagnosis of MSA and IPD is still challenging in clinical practice. • Absence of 'swallow-tail' sign is a valuable biomarker for IPD on SWI. • Putaminal hypointensity is a valuable biomarker for MSA on SWI. • Combined 'swallow- tail' sign and putaminal hypointensity increase diagnostic accuracy.
OBJECTIVE: To investigate the value of 'swallow-tail' sign and putaminal hypointensity on 3 T susceptibility-weighted imaging (SWI) for distinguishing multiple system atrophy (MSA) from idiopathic Parkinson's disease (IPD). METHODS: Three groups - 39 MSA patients, 18 IPD patients,and 31 healthy controls (HCs) - were administered a 3 T SWI sequence to evaluate 'swallow-tail' sign and putaminal hypointensity using visual scales from 0 to 2 and 0 to 3 scores, respectively. The diagnostic accuracy of the two signs separately and combined was calculated using a receiver operating characteristic curve, with clinical diagnosis as the gold standard. RESULTS: The scores of 'swallow-tail' sign were lower in IPD than in MSA or in HCs, as well as for putaminal hypointensity in IPD or HCs than in MSA (p < 0.05). The sensitivity and specificity of 'swallow-tail' sign and putaminal hypointensity were 87.9% and 83.3%, and 35.9% and 100%, respectively, in the respective patient groups. The area under the curve of combined signs was increased from 0.85 ('swallow tail') or 0.68 (putaminal hypointensity) to 0.93. CONCLUSION: The combination of 'swallow-tail' sign and putaminal hypointensity can increase the accuracy of discriminating between MSA and IPD. KEY POINTS: • Differential diagnosis of MSA and IPD is still challenging in clinical practice. • Absence of 'swallow-tail' sign is a valuable biomarker for IPD on SWI. • Putaminal hypointensity is a valuable biomarker for MSA on SWI. • Combined 'swallow- tail' sign and putaminal hypointensity increase diagnostic accuracy.
Authors: Vivek Sehgal; Zachary Delproposto; E Mark Haacke; Karen A Tong; Nathaniel Wycliffe; Daniel K Kido; Yingbiao Xu; Jaladhar Neelavalli; Djamel Haddar; Jürgen R Reichenbach Journal: J Magn Reson Imaging Date: 2005-10 Impact factor: 4.813
Authors: Y Wang; S R Butros; X Shuai; Y Dai; C Chen; M Liu; E M Haacke; J Hu; H Xu Journal: AJNR Am J Neuroradiol Date: 2011-11-03 Impact factor: 3.825
Authors: Luigi Zecca; Luigi Casella; Alberto Albertini; Chiara Bellei; Fabio A Zucca; Mireille Engelen; Andrzej Zadlo; Grzegorz Szewczyk; Mariusz Zareba; Tadeusz Sarna Journal: J Neurochem Date: 2008-07-04 Impact factor: 5.372
Authors: Thomas Eckert; Michael Sailer; Joern Kaufmann; Christoph Schrader; Thomas Peschel; Nils Bodammer; Hans Jochen Heinze; Mircea Ariel Schoenfeld Journal: Neuroimage Date: 2004-01 Impact factor: 6.556
Authors: S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet Journal: Neurology Date: 2008-08-26 Impact factor: 9.910
Authors: Stefan T Schwarz; Mohammed Afzal; Paul S Morgan; Nin Bajaj; Penny A Gowland; Dorothee P Auer Journal: PLoS One Date: 2014-04-07 Impact factor: 3.240
Authors: Frederick J A Meijer; Stefan C Steens; Anouke van Rumund; Anne-Marie van Cappellen van Walsum; Benno Küsters; Rianne A J Esselink; Marcel M Verbeek; Bastiaan R Bloem; Bożena Goraj Journal: Pol J Radiol Date: 2016-08-03
Authors: Shunsuke Koga; Shanu F Roemer; Philip W Tipton; Phillip A Low; Keith A Josephs; Dennis W Dickson Journal: Parkinsonism Relat Disord Date: 2020-05-16 Impact factor: 4.402
Authors: Carolin Gramsch; Iris Reuter; Oliver Kraff; Harald H Quick; Christian Tanislav; Florian Roessler; Cornelius Deuschl; Michael Forsting; Marc Schlamann Journal: PLoS One Date: 2017-10-10 Impact factor: 3.240